<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html>

<head>
    <title>Lilly</title>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <link rel="stylesheet" type="text/css" href="fonts/stylesheet.css">
    <link rel="stylesheet" type="text/css" href="jquery.qtip.css">
    <link rel="stylesheet" type="text/css" href="site.css">
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.6.1/jquery.min.js" type="text/javascript"></script>
    <script src="jquery.qtip-1.0.0-rc3-dm.js" type="text/javascript"></script>
    <script src="jquery.bpopup-0.5.1.min.js" type="text/javascript"></script>
    <script src="site.js" type="text/javascript"></script>
    <script type="text/javascript">
            $(document).ready(function() {
                // Match all <A/> links with a title tag and use it as the content (default).
                $('a.tooltip[title]').qtip({
                    position: {
                        adjust: {
                            x: 5,
                            y: 10
                        },
                        corner: {
                            target: 'topRight',
                            tooltip: 'topLeft'
                        }
                    },
                    style: {
                        width: 150,
                        name: 'dark',
                        tip: {
                            corner: 'topLeft',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });
                $('a.bigtooltip[title]').qtip({
                    position: {
                        adjust: {
                            x: 5,
                            y: 10
                        },
                        corner: {
                            target: 'topRight',
                            tooltip: 'topLeft'
                        }
                    },
                    style: {
                        width: 236,
                        name: 'dark',
                        tip: {
                            corner: 'topLeft',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });
                $('a.bigtooltip_left[title]').qtip({
                    position: {
                        adjust: {
                            x: 0,
                            y: 10
                        },
                        corner: {
                            target: 'topLeft',
                            tooltip: 'topRight'
                        }
                    },
                    style: {
                        width: 580,
                        name: 'dark',
                        tip: {
                            corner: 'topRight',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });

                /*
									$('a.tooltip_under[title]').qtip({
										position: {
											corner: {
												target: 'bottomCenter',
												tooltip: 'bottomCenter'
											}
										},
										style: {
											width: 96,
											name: 'gray'
										}
									});

									$('a.bigtooltip_under[title]').qtip({
										position: {
											corner: {
												target: 'bottomCenter',
												tooltip: 'bottomCenter'
											}
										},
										style: {
											width: 191,
											name: 'gray'
										}
									});
									$('.molecule-container li a label').each(function(){
										if($(this).html().length < 20){
											$(this).parent().css('padding-top', '3px');
											$(this).parent().css('line-height', '32px');
											$(this).parent().css('height', '32px');
										}
									});
									*/
                $('a.bigtooltip_under').hover(function() {
                    $(this).addClass('hovered');
                }, function() {
                    $(this).removeClass('hovered');
                });
                $('a.tooltip_under').hover(function() {
                    $(this).addClass('hovered');
                }, function() {
                    $(this).removeClass('hovered');
                });
            });
        </script>
</head>

<body>
    <div id="browser_notice">
        This website is optimized for visualization with Firefox and Internet Explorer (8 or 9)
    </div>
    <div id="container">
        <div id="header">
            <img src="./img/header.png" alt="Lilly - Development Pipeline" />
        </div>
        <div id="content">
            <div id="content-left">

                <h1 class="DINBold">
                    <a href="index.html">Pipeline Overview</a>
                </h1>

                <div class="menu">
                    <h2 class="DINBold">View by Therapeutic Area</h2>
                    <ul>
                        <li>
                            <a href="7.html" class="" title="Cardiovascular">Cardiovascular</a>
                        </li>
                        <li>
                            <a href="8.html" class="" title="Diabetes">Diabetes</a>
                        </li>
                        <li>
                            <a href="13.html" class="" title="Emerging Markets">Emerging Markets</a>
                        </li>
                        <li>
                            <a href="14.html" class="" title="Immunology">Immunology</a>
                        </li>
                        <li>
                            <a href="9.html" class="" title="Musculoskeletal">Musculoskeletal</a>
                        </li>
                        <li>
                            <a href="10.html" class="" title="Neuroscience">Neuroscience</a>
                        </li>
                        <li>
                            <a href="11.html" class="" title="Oncology">Oncology</a>
                        </li>
                    </ul>

                    <h2 class="DINBold">View by Molecule Type</h2>
                    <ul>
                        <li>
                            <a href="17.html" class="active" title="Chemical entity (small)">Chemical entity (small)</a>
                        </li>
                        <li>
                            <a href="18.html" class="" title="Biologic entity (large)">Biologic entity (large)</a>
                        </li>
                    </ul>
                </div>

                <p>
                    <a>Pipeline movement since April 19, 2016</a>
                </p>
                <p>
                    <a>Pipeline data through<br/>July 19, 2016</a>
                </p>

            </div>
            <div id="content-center">
                <h1 class="big_h1">CLINICAL DEVELOPMENT
                    <span>PIPELINE</span>
                </h1>
                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Regulatory Review</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-1' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-1" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Baricitinib
                                                            <br>rheumatoid
                                                            <br>arthritis</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-1">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Baricitinib (bar" i sye' ti nib)</div>
                                        <div class="molecule-position">
                                            <label>Regulatory Review</label>
                                            <label>Business area: Bio-Medicines</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009104 (baricitinib, formerly known as JAK1/JAK2 inhibitor) is a chemical entity that inhibits the activity of the Janus
                                        (JAK) 1 and 2 enzymes. LY3009104 is being studied for the treatment of rheumatoid
                                        arthritis.<br/><br/> For more information
                                        on baricitinib clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY3009104" target="_blank">here</a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137551">
                                                        <span style="color: #000000;">Results Of Clinical And Patient-Reported Outcomes Data For Baricitinib In Patients With Rheumatoid Arthritis To Be Presented At Annual European Congress Of Rheumatology (EULAR 2016)</span>
                                            </a>—June 7, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137554">
                                                        <span style="color: #000000;">Patient-Reported Outcomes Across Phase 3 Studies Of Baricitinib Demonstrate Statistically Significant Improvements In Physical Function And Quality Of Life Symptoms In Patients With Rheumatoid Arthritis (RA)</span>
                                            </a>—June 9, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137553">
                                                        <span style="color: #000000;">Baricitinib Significantly Reduces Joint Damage Progression In Rheumatoid Arthritis In Patients Who Do Not Respond To Conventional DMARDs</span>
                                            </a>—June 9, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137528">
                                                        <span style="color: #000000;">Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients With Rheumatoid Arthritis Who Had Inadequate Response To Biologics</span>
                                            </a>—March 31, 2016<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137509">
                                                        <span style="color: #000000;">Lilly and Incyte Announce Submission of New Drug Application to FDA for Oral Once-Daily Baricitinib for Treatment of Moderate-to-Severe Rheumatoid Arthritis</span>
                                            </a>—January 19, 2016<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137493">
                                                        <span style="color: #000000;">Lilly And Incyte Announce Patients Treated With Baricitinib Demonstrated Significant Improvement In Signs And Symptoms Of Rheumatoid Arthritis Compared With Methotrexate</span>
                                            </a>—November 7, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137496">
                                                        <span style="color: #000000;">Detailed Results Demonstrate Baricitinib Superiority To Adalimumab In Improving Signs And Symptoms Of Rheumatoid Arthritis</span>
                                            </a>—November 7, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137489">
                                                        <span style="color: #000000;">Results Of Two Pivotal Baricitinib Trials To Be Presented At 2015 American College Of Rheumatology Annual Meeting</span>
                                            </a>—November 4, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137486">
                                                        <span style="color: #000000;">Lilly And Incyte Announce Webcast To Discuss Baricitinib Phase 3 Data</span>
                                            </a>—October 27, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137479">
                                                        <span style="color: #000000;">Baricitinib Demonstrates Superiority To Adalimumab In Improving Signs And Symptoms Of Rheumatoid Arthritis In Pivotal Phase 3 Study</span>
                                            </a>—October 14, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137468">
                                                        <span style="color: #000000;">Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal Phase 3 Study in Patients with Rheumatoid Arthritis</span>
                                            </a>
                                            – September 29, 2015</span><br/><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137438">
                                                        <span style="color: #000000;">Lilly And Incyte Unveil Detailed Data On Two Pivotal Studies Of Baricitinib In Rheumatoid Arthritis</span>
                                            </a>—June 10, 2015<br/><br/></span>
                                        </p>
                                        <span style="color: #000000;">
                                                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137427">
                                                    <span style="color: #000000;">Lilly And Incyte Announce Webcast To Discuss Baricitinib Phase III Data</span>
                                        </a>—May 28, 2015<br/><br/></span>
                                        <p>
                                            <span style="color: #000000;" data-mce-mark="1">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137393">
                                                        <span style="color: #000000;" data-mce-mark="1">Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3 Study</span>
                                            </a>
                                            – February 23, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;" data-mce-mark="1">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137374">
                                                        <span style="color: #000000;" data-mce-mark="1">Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis</span>
                                            </a>– December 9, 2014
                                            <br/></span><br/><br/>
                                            <span style="color: #000000;" data-mce-mark="1">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137205">
                                                        <span style="color: #000000;" data-mce-mark="1">Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis</span>
                                            </a>
                                            – June 13, 2013<br/></span><br/><br/>
                                            <span style="color: #000000;" data-mce-mark="1">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=135502" target="_blank">
                                                        <span style="color: #000000;" data-mce-mark="1">Lilly and Incyte Announce Additional Phase IIb Baricitinib Data, Including MRI Results, in Patients with Rheumatoid Arthritis</span>
                                            </a>
                                            – November 13, 2012</span><br/><br/><br/>
                                            <span style="color: #000000;" data-mce-mark="1">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=129335" target="_blank">
                                                        <span style="color: #000000;" data-mce-mark="1">Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis</span>
                                            </a>
                                            – June 8, 2012</span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;"></span>
                                        </p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                                        $("#click-content-1").bind('click', function() {
                                            $("#content-1").bPopup();
                                            return false;
                                        });
                                    </script>
                            </li>
                            <li id='cell-2' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-2" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>*Empagliflozin
                                                            <br>
                                                            CV outcomes
                                                            <br>data</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-2">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">*Empagliflozin CV outcomes data</div>
                                        <div class="molecule-position">
                                            <label>Regulatory Review</label>
                                            <label>Business area: Diabetes</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        Empagliflozin is a chemical entity that inhibits the sodium glucose co-transporter-2 (SGLT 2). Recently published data from
                                        the Empagliflozin Cardiovascular Outcomes Trial, EMPA-REG-OUTCOME, is under regulatory
                                        review for inclusion in the currently approved labels for Empagliflozin. Empagliflozin
                                        is being studied in collaboration with Boehringer Ingelheim.
                                        <br/><br/> For more information on Empagliflozin clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=Empagliflozin&Search=Search" target="_blank">here</a>.
                                        <br/>
                                        <br/>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.
                                        </p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137567">
                                                        <span style="color: #000000;">FDA Advisory Committee recommends approval of Jardiance® (empagliflozin) for cardiovascular indication in 12-11 vote</span>
                                            </a>—June 28, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137559">
                                                        <span style="color: #000000;">New Jardiance® (Empagliflozin) Data Show That Reduced Risk For Cardiovascular (CV) Death Was Consistent Across Age Groups In Adults With Type 2 Diabetes</span>
                                            </a>—June 12, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <span data-mce-mark="1">
                                                        <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137533">
                                                            <span style="color: #000000;" data-mce-mark="1">Jardiance® (Empagliflozin) To Be Studied For The Treatment Of People With Chronic Heart Failure</span>
                                            </a>
                                            </span>—April 19, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137511">
                                                        <span style="color: #000000;">U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)</span>
                                            </a>—January 25, 2016<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137495">
                                                        <span style="color: #000000;">New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline</span>
                                            </a>—November 9, 2015<br/></span><br/><br/>
                                            <span style="color: #000000;">
                                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137481">
                                                        <span style="color: #000000;">Jardiance® (Empagliflozin) Is The Only Diabetes Medication To Show A Significant Reduction In Both Cardiovascular Risk And Cardiovascular Death In A Dedicated Outcome Trial</span>
                                            </a>—September 17, 2015</span>
                                        </p>
                                        <div>
                                            <span style="color: #000000;"></span>
                                        </div>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                                        $("#click-content-2").bind('click', function() {
                                            $("#content-2").bPopup();
                                            return false;
                                        });
                                    </script>
                            </li>
                            <li id='cell-3' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-3" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>*Empagliflozin + Metformin XR
                                                            <br>
                                                            diabetes</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-3">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Empagliflozin + Metformin XR
                                        </div>
                                        <div class="molecule-position">
                                            <label>Regulatory Review</label>
                                            <label>Business area: Diabetes</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        BI10773 (Empagliflozin) is a chemical entity that inhibits the sodium glucose co-transporter-2 (SGLT 2). BI10773 is being
                                        studied as a fixed dose combination with metformin-extended release in collaboration
                                        with Boehringer Ingelheim as a treatment for type 2 diabetes.
                                        <br/><br> For more information on Empagliflozin + Metformin XR clinical studies,
                                        click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=Empagliflozin+%2B+Metformin+XR+&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">NOTE: If you click on the link above it will take you to a site maintained by a third
                                            party, which is solely responsible for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>None during this time period.</p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                                $("#click-content-3").bind('click', function() {
                                    $("#content-3").bPopup();
                                    return false;
                                });
                            </script>
                            </li>
                            <li id='cell-4' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-4" class=" nilex_cell tooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/checked.png" alt="" />
                                                <div class="molecule-inner-content">
                                                    <label>*Linagliptin + Metformin XR<br>diabetes</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-4">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/checked.png" alt="" /></div>

                                        <div class="mtitle DINBold">Linagliptin + Metformin XR</div>
                                        <div class="molecule-position">
                                            <label>Regulatory Review</label>
                                            <label>Business area: Diabetes</label>
                                            <label style='display:block;'>Regulatory Approval Achieved</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        Linagliptin is a chemical entity that inhibits the enzyme dipeptidyl peptidase 4 (DPP-4). Linagliptin is being studied as
                                        a fixed dose combination with metformin-extended release in collaboration with Boehringer
                                        Ingelheim as a treatment for type 2 diabetes.
                                        <br/><br> For more information on Linagliptin + Metformin XR clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=Linagliptin+Metformin&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137546">
                                        <span style="color: #000000;">U.S. FDA Approves Once-Daily Jentadueto® XR (Linagliptin And Metformin Hydrochloride Extended-Release) Tablets For Adults With Type 2 Diabetes</span>
                                            </a>—May 31, 2016</span>
                                        </p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                        $("#click-content-4").bind('click', function() {
                            $("#content-4").bPopup();
                            return false;
                        });
                    </script>
                            </li>
                            <li id='cell-5' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-6' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase III</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-37' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-37" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>*BACE - AZD3293
                                        </br>
                                        Alzheimer's
                                    </label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-37">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">AZD3293</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Bio-Medicines</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3314814 (AZD 3293), a chemical entity, is an oral beta secretase cleaving enzyme (BACE) inhibitor. LY3314814 is being studied
                                        for the treatment of Alzheimer's disease.<br/><br>                                        For more information on BACE - AZD3293 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=AZD3293+&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>PRESS RELEASES (1/1/2010-7/19/2016)</h1>
                                        <p>
                                            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137531">Eli Lilly And Company And AstraZeneca Announce Continuation Of Pivotal Clinical Trial For People With Early Alzheimer's Disease</a>                                            - April 8, 2016</p>
                                        <p></p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
            $("#click-content-37").bind('click', function() {
                $("#content-37").bPopup();
                return false;
            });
        </script>
                            </li>
                            <li id='cell-38' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-38" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib<br>
                                    metastatic breast
                                </br>
                                cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-38">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LLY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of metastatic
                                        breast cancer.
                                        <br/><br> For more information on LY2835219 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2835219" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <span style="color: #000000;">
                <strong>PRESS RELEASES</strong>
                (1/1/2010-7/19/2016)</span>
                                        </h1>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137570">
                    <span style="color: #000000;">Lilly And Boehringer Ingelheim Announce Clinical Trial Collaboration In Metastatic Breast Cancer</span>
                                            </a>—July 13, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137549">
                    <span style="color: #000000;">Lilly Announces Results From MONARCH 1 Trial Of Abemaciclib Monotherapy</span>
                                            </a>—June 3, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137547">
                    <span style="color: #000000;">Lilly Announces Webcast To Discuss Abemaciclib Data</span>
                                            </a>—May 31, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137540">
                    <span style="color: #000000;">ASCO Data Underscore Lilly's Diverse Oncology Pipeline And Portfolio</span>
                                            </a>—May 18, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137472">
                    <span style="color: #000000;">Lilly Receives FDA Breakthrough Therapy Designation For Abemaciclib - A CDK 4 And 6 Inhibitor - In Advanced Breast Cancer</span>
                                            </a>—October 8, 2015<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137407">
                    <span style="color: #000000;">Lilly Releases Early-Stage Pipeline Data At AACR Annual Meeting 2015</span>
                                            </a>—April 20, 2015<br/><br/></span>
                                        </p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
    $("#click-content-38").bind('click', function() {
        $("#content-38").bPopup();
        return false;
    });
</script>
                            </li>
                            <li id='cell-39' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-39" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>*Empagliflozin
                        <br>type 1
                        <br>diabetes</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-39">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Empagliflozin</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Diabetes</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        BI10773 (Empagliflozin) is a chemical entity that inhibits the sodium glucose co-transporter-2 (SGLT 2). BI10773 is being
                                        studied in collaboration with Boehringer Ingelheim as a treatment for type 1 diabetes.
                                        <br/><br> For more information on BI10773 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=BI10773" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>None during this time period.<br/><br/></p>
                                        <h1>
                                            <strong></strong>
                                        </h1>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-39").bind('click', function() {
    $("#content-39").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-40' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-40" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib
                <br>
                lung cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-40">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of KRAS
                                        mutant non small cell lung cancer.
                                        <br/><br> For more information on abemaciclib clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2835219" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>
                                            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137407">Lilly Releases Early-Stage Pipeline Data At AACR Annual Meeting 2015</a>—April
                                            20, 2015<br/><br/>
                                            <a href="https://investor.lilly.com/releasedetail.cfm?ReleaseID=848054">Abemaciclib - Lilly's Oral CDK 4/6 Inhibitor - Shows Single-Agent Activity In A Phase I Study For Patients With A Specific Type Of Lung Cancer</a>                                            – May 12, 2014</p>
                                        <p></p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-40").bind('click', function() {
    $("#content-40").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-54' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-54" class=" diagnostic_cell tooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/scientific_name_given.png"
                                                    alt="" />
                                                <div class="molecule-inner-content">
                                                    <label>Flortaucipir F 18</label>
                                                    <label class="toolt">Diagnostic</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-54">
                                    <div class="molecule-title">
                                        <div class="minfobg"><img src="./img/scientific_name_given.png" alt="" /></div>
                                        <div class="mtitle DINBold">Flortaucipir F 18 (flor tau’ si pir)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Research</label>
                                            <label style='display:block;'>Nonproprietary Name Granted</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        18F-AV-1451 (Flortaucipir F 18) is a chemical entity PET imaging agent being studied for the imaging of Tau pathology.<br/><br>                                        For more information on Flortaucipir F 18 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=18F-AV-1451" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>

                                        <br/><br/>
                                        <div>
                                            <h1>
                                                <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                            </h1>
                                        </div>
                                        <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137332">Lilly To Showcase Data From Its Alzheimer's Disease Portfolio At The Alzheimer's Association International Conference 2014 (AAIC 2014)</a>—July
                                        8, 2014<br/><br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-54").bind('click', function() {
    $("#content-54").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-42' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-43' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-44' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-45' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-46' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-47' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-48' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-49' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-50' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-51' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-52' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-53' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-54' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase II</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-55' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-55" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Prexasertib<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-55">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Prexasertib (prex” a ser’ tib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2606368 monomesylate monohydrate (formerly known as Chk1 inhibitor) is a chemical entity that preferentially binds to and
                                        inhibits checkpoint kinase 1 (Chk1), a global regulator of the mammalian cell cycle
                                        and, to a lesser extent, inhibits Chk2. LY2606368 monomesylate monohydrate is being
                                        studied for the treatment of cancer.<br/><br>                                        For more information on LY2606368 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2606368" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-55").bind('click', function() {
    $("#content-55").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-56' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-56" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Galunisertib<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-56">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Galunisertib (gal ue” ni ser’ tib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2157299 monohydrate (formerly known as TGFb R1 kinase inhibitor) is a chemical entity that selectively blocks transforming
                                        growth factor-β receptor I kinase and TGF-b signaling. LY2157299 monohydrate is being
                                        studied for the treatment of pancreatic and hepatocellular cancer.
                                        <br/><br> For more information on LY2157299 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2157299" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-56").bind('click', function() {
    $("#content-56").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-57' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-57" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Merestinib
<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-57">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Merestinib cancer (mer es’ ti nib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2801653 (formerly known as c-Met inhibitor) is a chemical entity that has been shown in vitro to be a reversible type II
                                        ATP-competitive inhibitor of MET, a receptor for hepatocyte growth factor. Preclinical
                                        testing also has shown LY2801653 to inhibit several other receptor tyrosine oncokinases
                                        including MST1R, FLT3, AXL, MERTK, TEK, ROS1, and DDR1/2 and the serine/threonine
                                        kinases MKNK1/2. LY2801653 is being studied for the treatment of cancer.
                                        <br/><br> For more information on LY2801653 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2801653" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-57").bind('click', function() {
    $("#content-57").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-58' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-58" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Edivoxetine
<br>CNS disorder</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-58">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Edivoxetine (e" di vox' e teen hye" droe klor' ide)
                                        </div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Bio-Medicines</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2216684 (edivoxetine) is a chemical entity that inhibits the reuptake of norepinephrine. LY2216684 is being studied for
                                        multiple CNS disorders. Molecule is owned by a 3rd party, Lilly retains rights.
                                        <br/><br> For more information on edivoxetine clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2216684" target="_blank">here</a>.<br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-58").bind('click', function() {
    $("#content-58").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-59' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-59" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>FGF receptor inh
<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-59">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">FGF Receptor Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2874455 (FGF receptor inhibitor), a chemical entity, inhibits autophosphorylation of fibroblast growth factor (FGF) receptors
                                        1, 2, 3 and 4, which is required for activation of FGF-induced downstream signaling.
                                        LY2874455 is being studied for the treatment of cancer.<br/><br>                                        For more information on LY2874455 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2874455" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-59").bind('click', function() {
    $("#content-59").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-60' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-60" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>NOTCH inhibitor<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-60">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">NOTCH inhibitor cancer</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3039478 (NOTCH Inhibitor) is a new chemical entity being studied for the treatment of cancer.<br/><br>                                        For more information on LY3039478 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3039478&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-60").bind('click', function() {
    $("#content-60").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-61' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-61" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>PI3 kinase/<br>mTOR dual inh<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-61">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">PI3 Kinase/mTOR Dual Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3023414 (PI3 Kinase/mTOR dual Inhibitor) is a chemical entity being studied for the treatment of prostate cancer and NSCLC.
                                        <br/><br> For more information on LY3023414 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3023414&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-61").bind('click', function() {
    $("#content-61").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-62' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-62" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ralimetinib
<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-62">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ralimetinib (ral’’ i me’ ti nib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2228820 dimesylate (formerly known as p38 MAP kinase inhibitor) is a chemical entity that preferentially binds to and inhibits
                                        p38 MAP kinase. LY2228820 dimesylate is being studied for the treatment of ovarian
                                        cancer.<br/><br> For more information on
                                        LY2228820 dimesylate clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2228820" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>

                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-62").bind('click', function() {
    $("#content-62").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-63' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-63" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Baricitinib<br>atopic dermatitis</label>
                                                    <label class="toolt">Select NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-63">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Baricitinib
                                            <br> atopic dermatitis</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Bio-Medicines</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009104 (baricitinib, formerly known as JAK1/JAK2 Inhibitor) is a chemical entity that inhibits the activity of the Janus
                                        (JAK) 1 and 2 enzymes. LY3009104 is being studied for the treatment of atopic dermatitis.
                                        <br/><br> For more information on LY3009104 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3009104" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-63").bind('click', function() {
    $("#content-63").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-64' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-64" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Baricitinib<br>systemic lupus erythematosus</label>
                                                    <label class="toolt">Select NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-64">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Baricitinib<br>systemic lupus erythematosus</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Bio-Medicines</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009104 (baricitinib, formerly known as JAK1/JAK2 Inhibitor) is a chemical entity that inhibits the activity of the Janus
                                        (JAK) 1 and 2 enzymes. LY3009104 is being studied for the treatment of systemic lupus
                                        erythematosus.
                                        <br/><br> For more information on LY3009104 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3009104" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-64").bind('click', function() {
    $("#content-64").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-65' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-65" class=" nilex_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib<br>squamous NSCLC</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-65">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of squamous
                                        NSCLC.

                                        <br/><br> For more information on LY2835219 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY2835219&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-65").bind('click', function() {
    $("#content-65").bPopup();
    return false;
});
</script>
                            </li>

                            <li id='cell-71' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-71" class=" nilex_cell tooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/lost_molecule.png" alt=""
                                                />
                                                <div class="molecule-inner-content">
                                                    <label>Baricitinib
<br>
diabetic nephropathy</label>
                                                    <label class="toolt">Select NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-71">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/lost_molecule.png" alt="" /></div>

                                        <div class="mtitle DINBold">Baricitinib
                                            <br> diabetic nephropathy</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Bio-Medicines</label>
                                            <label style='display:block;'>Lost Through Attrition</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009104 (baricitinib, formerly known as JAK1/JAK2 Inhibitor) is a chemical entity that inhibits the activity of the Janus
                                        (JAK) 1 and 2 enzymes. LY3009104 is being studied for the treatment of diabetic nephropathy.

                                        <br/><br> For more information on LY3009104 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3009104" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-71").bind('click', function() {
    $("#content-71").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-72' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-72" class=" nilex_cell tooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/lost_molecule.png" alt=""
                                                />
                                                <div class="molecule-inner-content">
                                                    <label>Baricitinib
<br>
psoriasis</label>
                                                    <label class="toolt">Select NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-72">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/lost_molecule.png" alt="" /></div>

                                        <div class="mtitle DINBold">Baricitinib
                                            <br> psoriasis
                                        </div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Bio-Medicines</label>
                                            <label style='display:block;'>Lost Through Attrition</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009104 (baricitinib, formerly known as JAK1/JAK2 Inhibitor) is a chemical entity that inhibits the activity of the Janus
                                        (JAK) 1 and 2 enzymes. LY3009104 is being studied for the treatment of psoriasis.

                                        <br/><br> For more information on LY3009104 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3009104" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-72").bind('click', function() {
    $("#content-72").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-66' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-66" class=" diagnostic_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Florbenazine</label>
                                                    <label class="toolt">Diagnostic</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-66">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Florbenazine (flor ben' a zeen)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        Florbenazine (18F-AV-133) is a chemical entity PET imaging agent being studied for the imaging of Parkinson's disease pathology.
                                        <br/><br> For more information on 18F-AV-133 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=AV-133&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>

                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-66").bind('click', function() {
    $("#content-66").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-67' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-68' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-69' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-70' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>

                            <li id='cell-73' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-74' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-75' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-76' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-77' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-78' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-79' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-80' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-81' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-82' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-83' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-84' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-85' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-86' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-87' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-88' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-89' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-90' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase I</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-91' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-91" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>diabetes</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-91">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">diabetes</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        New chemical entity. Molecule is owned by a 3rd party, Lilly retains rights.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-91").bind('click', function() {
    $("#content-91").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-92' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-92" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>DGAT-2 inhibitor dyslipidemia</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-92">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">DGAT-2 inhibitor dyslipidemia</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "DGAT-2 inhibitor" is a new chemical entity being studied for the treatment of dyslipidemia.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-92").bind('click', function() {
    $("#content-92").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-93' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-93" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>BTK inhibitor<br>immunology</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-93">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">BTK inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "BTK inhibitor" is a new chemical entity being studied for the treatment of immune diseases.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-93").bind('click', function() {
    $("#content-93").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-94' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-94" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>BACE inhibitor
<br/>
Alzheimer’s</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-94">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">BACE inhibitor Alzheimer's</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "BACE Inhibitor" is a new chemical entity being studied for the treatment of Alzheimer's disease.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-94").bind('click', function() {
    $("#content-94").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-95' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-95" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>D1 potentiator dementia
</label>
                                                    <label class="toolt">New Molecular Entity.</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-95">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">D1 potentiator</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "D1 potentiator" is a new chemical entity being studied for the treatment of dementia.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-95").bind('click', function() {
    $("#content-95").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-96' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-96" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Pomaglumetad methionil<br>schizophrenia</label>
                                                    <label class="toolt">New molecular entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-96">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Pomaglumetad methionil</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2140023 monohydrate (pomaglumetad methionil) is a chemical entity agonist of the metabotropic glutamate 2/3 receptors.
                                        LY2140023 licensed to Denovo Biopharma to identify genetic biomarkers and to screen
                                        for appropriate patient subsets for further study in future clinical trials.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-96").bind('click', function() {
    $("#content-96").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-97' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-97" class=" nme_cell tooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/achived_milestone_molecule.png"
                                                    alt="" />
                                                <div class="molecule-inner-content">
                                                    <label>Chk1 inhibitor cancer</label>
                                                    <label class="toolt">New Molecular Entity
</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-97">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/achived_milestone_molecule.png" alt="" /></div>

                                        <div class="mtitle DINBold">Chk1 Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                            <label style='display:block;'>Molecule That Achieved Milestone
</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Chk1 Inhibitor" is a new chemical entity being studied for the treatment of cancer. Molecule is owned by a 3rd party, Lilly
                                        retains rights.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-97").bind('click', function() {
    $("#content-97").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-98' class=' '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-98" class=" nme_cell tooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Pan-Raf<br>inhibitor
<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup " id="content-98">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Pan-Raf inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Pan-Raf inhibitor" is a new chemical entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-98").bind('click', function() {
    $("#content-98").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-99' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-100' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-101' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-102' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-103' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-104' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-105' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-106' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-107' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-108' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-109' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-110' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-111' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-112' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-113' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-114' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-115' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-116' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-117' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-118' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-119' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-120' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-121' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-122' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-123' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-124' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-125' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-126' class=' empty'>
                                <span class=" empty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>

                </div>

                <div class="disclaimer">
                    <b>Pipeline Disclaimer</b><br/>The information included on this site reflects Eli Lilly and Company's
                    clinical development pipeline and is not intended for promotional purposes. It includes both new molecular
                    entities as well as select new indications or line extensions of currently-approved products, that are
                    in clinical development. There are significant risks and uncertainties in pharmaceutical research and
                    development. Scientific and regulatory hurdles may cause pipeline molecules to be discontinued, delayed
                    or fail to reach the market. There can be no guarantee that pipeline molecules will receive regulatory
                    approval or that they will prove to be commercially successful. Information is current as of July 19,
                    2016. Lilly assumes no duty to update this information.
                    <br><br> For competitive reasons, some pipeline molecules are not identified; in those instances, only
                    the therapeutic area in which the molecule is being studied is listed.</div>
                <p class="footer">
                    Property of Eli Lilly and Company.
                </p>
            </div>
            <div id="content-right">

                <div class="molecule-info2">
                    <h1>Legend</h1>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/new_molecule.png" alt="" />
                            <div class="molecule-text">New Molecule</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/achived_milestone_molecule.png" alt="" />
                            <div class="molecule-text">Molecule That Achieved Milestone
                            </div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/scientific_name_given.png" alt="" />
                            <div class="molecule-text">Nonproprietary Name Granted</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/later_phase_molecule.png" alt="" />
                            <div class="molecule-text">Molecule Moved to Earlier Phase</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/lost_molecule.png" alt="" />
                            <div class="molecule-text">Lost Through Attrition</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/checked.png" alt="" />
                            <div class="molecule-text">Regulatory Approval Achieved</div>
                        </div>
                    </a>
                    <div class="molecule-data">
                        *Commercial Collaboration
                    </div>
                </div>
                <ul class="molecule-info">
                    <li>
                        <span class="nme_cell">
<b>NME</b>
</span>
                    </li>

                    <li>
                        <span class="nilex_cell">
<b>Select NILEX</b>
</span>
                    </li>

                    <li>
                        <span class="diagnostic_cell">
<b>Diagnostic</b>
</span>
                    </li>
                </ul>
                <div id="full_legend_link">
                    For more information about Lilly's interactive pipeline website,
                    <a href="full_legend.html">click here</a>
                </div>
            </div>
        </div>
        <div id="footer"></div>
    </div>

    <script type="text/javascript">
$(window).load(function() {
    var cCenterHeight = $('#content-center').height();
    var cLeftHeight = $('#content-left').height();
    var paddingTop = cCenterHeight - cLeftHeight - 10;
    if (paddingTop > 0) {
        //$('.footer').css('padding-top', parseInt(paddingTop)+'px');
    }
    $('.molecule-container').each(function() {

        if (!$(this).has('li').length) {
            $(this).css('padding', '0');
        }

        $(this).find('a.big').each(function() {

            var a_height = $(this).height();

            var label_height = $(this).find('label').height();
            if (label_height != 0) {
                $(this).find('label').css('padding-top', parseInt(((a_height - label_height) / 2) - 5));
            } else {
                $(this).find('label').css('padding-top', 12);
            }
        });

    });
    //Set default open/close settings $('.molecule-container').hide(); //Hide/close all containers $('.cells-container-inner h1:last').addClass('active').next().hide();

});
</script>

    <script type="text/javascript">
$(document).ready(function() {
    // align text in center
    $('.molecule-info2 .molecule-data').each(function() {
        var molecule_text_height = $(this).children('.molecule-text').height();
        if (molecule_text_height < 23) {
            $(this).children('.molecule-text').css('padding-top', (23 - molecule_text_height) / 2);
        }
    });
    //On Click
    $('.cells-container-inner h1.toggle').click(function() {
        if ($(this).hasClass('active')) {
            $(this).toggleClass('active').next().slideUp(); //Add "active" state to clicked trigger and slide down the immediate next container
            $(this).children('label').toggleClass('exp_open');
        } else {
            $(this).toggleClass('active').next().slideDown(); //Add "active" state to clicked trigger and slide down the immediate next container
            $(this).children('label').toggleClass('exp_open');
        }
        return false; //Prevent the browser jump to the link anchor
    });
    $('.molecule-container').each(function() {
        var i = 0;
        var j = 0;
        var a = new Array(6);
        $(this).find('li').each(function() {
            if ($(this).hasClass('empty')) {
                a[i] = $(this);
                j++;
            }
            i++;
            if (j == 6) {
                for (var k = 0; k < 6; k++) {
                    a[k].remove();
                }
            }
            if (i == 6) {
                i = 0;
                j = 0;
            }
        });
    });
});
</script>
    <!-- START OF SmartSource Data Collector TAG -->
    <!-- Copyright (c) 1996-2010 WebTrends Inc.  All rights reserved. -->
    <!-- Version: 9.3.0 -->
    <!-- Tag Builder Version: 3.1  -->
    <!-- Created: 2/10/2011 5:17:20 PM -->
    <script src="webtrends.js" type="text/javascript"></script>
    <!-- ----------------------------------------------------------------------------------- -->
    <!-- Warning: The two script blocks below must remain inline. Moving them to an external -->
    <!-- JavaScript include file can cause serious problems with cross-domain tracking.      -->
    <!-- ----------------------------------------------------------------------------------- -->
    <script type="text/javascript">
    //<![CDATA[
var _tag = new WebTrends();
_tag.dcsGetId();

    //]]>
</script>
    <script type="text/javascript">
    //<![CDATA[
_tag.dcsCustom = function() {
    // Add custom parameters here. _tag.DCSext.param_name=param_value;
}
_tag.dcsCollect();

    //]]>
</script>
    <noscript>
        <div><img alt="DCSIMG" id="DCSIMG" width="1" height="1" src="http://statse.webtrendslive.com/dcskykqjqvz5bd05pjea7z15r_7k3s/njs.gif?dcsuri=/nojavascript&amp;WT.js=No&amp;WT.tv=9.3.0&amp;WT.dcssip=www.lilly.com,lilly.com,elilly.com"
            /></div>
    </noscript>
    <!-- END OF SmartSource Data Collector TAG -->
</body>

</html>